Viewing Study NCT05447702


Ignite Creation Date: 2025-12-25 @ 4:04 AM
Ignite Modification Date: 2026-01-15 @ 1:48 PM
Study NCT ID: NCT05447702
Status: RECRUITING
Last Update Posted: 2023-05-22
First Post: 2022-06-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Camrelizumab Plus Apatinib and Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)
Sponsor: West China Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module